<DOC>
	<DOCNO>NCT00731679</DOCNO>
	<brief_summary>To evaluate efficacy 14-day course rifaximin give 3 time day vs. placebo provide adequate relief IBS symptom .</brief_summary>
	<brief_title>Rifaximin 3 Times/Day ( TID ) Non-Constipation Irritable Bowel Syndrome ( IBS )</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Irritable Bowel Syndrome</mesh_term>
	<mesh_term>Rifaximin</mesh_term>
	<mesh_term>Rifamycins</mesh_term>
	<criteria>Confirmed IBS diagnosis per Rome II diagnosis IBS . Colonoscopy within 2 year part IBS diagnostic evaluation . Has active symptom nonconstipation IBS baseline measure average daily score abdominal pain/discomfort , bloating , stool consistency . Symptoms constipation . History gastrointestinal disease . Type 1 2 diabetes . Lactose intolerance control lactosefree diet .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2014</verification_date>
	<keyword>IBS</keyword>
	<keyword>Abdominal pain</keyword>
	<keyword>Bloating</keyword>
	<keyword>Diarrhea</keyword>
	<keyword>Rifaximin</keyword>
</DOC>